Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,784 public trials 1,781 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Active, not recruiting

Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.

NCT05038735

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Novartis Investigative Site Sint-Niklaas, Oost Vlaanderen, Belgium
  • Novartis Investigative Site Brussels, Belgium
  • Novartis Investigative Site Brussels, Belgium
  • Novartis Investigative Site Ghent, Belgium
View all 69 locations
View Trial Details
Active, not recruiting

Sentinel Node Biopsy in Breast Cancer: Omission of Axillary Clearance After Macrometastases. A Randomized Trial.

NCT02240472

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
Locations
  • Sygehus Sonderjylland Aabenraa, Denmark
  • Aalborg University Hospital Aalborg, Denmark
  • Aarhus University Hospital Aarhus, Denmark
  • Rigshospitalet Copenhagen, Denmark
View all 33 locations
View Trial Details
Active, not recruiting

Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)

NCT04964934

Conditions
Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Hot Springs, Arkansas, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Long Beach, California, United States
View all 264 locations
View Trial Details
Active, not recruiting

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer

NCT02032823

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Research Site Anchorage, Alabama, United States
  • Research Site Anchorage, Alaska, United States
  • Research Site Gilbert, Arizona, United States
  • Research Site Fort Smith, Arkansas, United States
View all 698 locations
View Trial Details
Active, not recruiting

A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer

NCT06112379

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Research Site Daphne, Alabama, United States
  • Research Site Prescott, Arizona, United States
  • Research Site Jonesboro, Arkansas, United States
  • Research Site Rogers, Arkansas, United States
View all 283 locations
View Trial Details

Related conditions